Brief: Bridge Biotherapeutics, Scripps Research Launch Research Collaboration
07/02/2022 22:25
Feb 7 (Reuters) - Bridge Biotherapeutics Inc 288330.KQ :
* BRIDGE BIOTHERAPEUTICS AND SCRIPPS RESEARCH LAUNCH
RESEARCH
COLLABORATION TO DEVELOP DISCOVERY PLATFORM AND NOVEL COVALENT
PROBES BASED ON CHEMICAL BIOLOGY AND CHEMOPROTEOMICS
Source text for Eikon: ID:nPnf67x2a
Further company coverage: 288330.KQ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Parataxis Korea
See all newsBrief: Parataxis, Bridge Biotherapeutics Ink Deal to List Bitcoin Treasury Firm on Korea's KOSDAQ
Brief: Bridge Biotherapeutics Announces Completion Of Enrollment In The Phase 2A Clinical Study Of BBT-877 For The Treatment Of Idiopathic Pulmonary Fibrosis
Brief: Bridge Biotherapeutics Launches A Research Collaboration With Emory University School Of Medicine
Brief: Bridge Biotherapeutics Announces A Research Collaboration With The University Of Colorado School Of Medicine
Brief: Bridge Biotherapeutics To Conduct Capital Increase Of 2 Billion Won For Operational Funds